Inhibition of Herpes Simplex Virus Reactivation by Dipyridamole

Richard B. Tenser, Andrew Gaydos, Kathleen A. Hay

Antimicrobial Agents and Chemotherapy · 2001 · 82 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Herpes simplex virus (HSV) reactivation from latency was investigated. Reactivation of thymidine kinase-negative HSV, which is defective for reactivation, was greatly enhanced by thymidine (TdR). The reactivation-enhancing effect of TdR was blocked by dipyridamole (DPM), a known nucleoside transport inhibitor. DPM also inhibited wild-type HSV reactivation, suggesting potential antiviral use.

References

16